SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hunter Biden’s Laptop (LAPTOP) is a memecoin referencing the eponymous Hunter Biden laptop sensation that’s been a fixture in global media news cycles for the past six years. LAPTOP is a fungible, freely transferable, non-yield-bearing ERC-20 token on Base. As a memecoin, LAPTOP has no utility, but incorporates two novel distribution mechanics designed to promote long-term community growth: a large community airdrop and an event-based supply mechanism.

Hunter Biden's Laptop

The community is focused on the rapid and severe collapse of the newly launched meme coin, with many traders labeling the event a definitive rug pull. Debate centers on the speculative nature of politically-themed crypto projects, with participants expressing both frustration over financial losses and cynical reactions toward the coin's association with Hunter Biden.

JD.com, Inc. is a technology-driven E-commerce company, which engages in the sale of electronics products and general merchandise products, including audio, video products, and books. It operates in the following segments: JD Retail, JD Logistics, and New Businesses. The JD Retail segment offers online retail, online marketplace, and marketing services. The JD Logistics segment includes internal and external logistics businesses. The New Businesses segment is composed of JD Property, Jingxi, overseas businesses and technology initiatives. The company was founded on June 18, 1998, by Qiang Dong Liu and is headquartered in Beijing, China.

JD.com Inc - ADR

Investors are expressing significant frustration over the stock's persistent decline, with many characterizing the ongoing price weakness as a repetitive pattern that lacks fundamental support or recovery momentum. Sentiment remains deeply divided between those viewing the current valuation as a deep-value buying opportunity due to strong fundamentals and cash positions, and others warning that the stock is a 'value trap' trapped in a long-term downtrend.

Visa, Inc. engages in the provision of digital payment services. It also facilitates global commerce through the transfer of value and information among a global network of consumers, merchants, financial institutions, businesses, strategic partners, and government entities. It offers debit cards, credit cards, prepaid products, commercial payment solutions, and global automated teller machines. The company was founded by Dee Hock in 1958 and is headquartered in San Francisco, CA.

Visa Inc - Ordinary Shares - Class A

Visa Inc

Visa is rallying significantly following a strong quarterly earnings report that featured a revenue and EPS beat alongside a raised full-year outlook. The positive sentiment is further bolstered by management's announcement of a substantial share buyback program and commentary highlighting resilient consumer spending.

Air Canada engages in the provision of airline transportation services. Its services cover full-service airline, scheduled passenger and cargo services, serving more than two hundred airports on six continents. It operates through the following geographical segments: Canada, U.S. Transborder, Atlantic, Pacific, and Other. The company was founded on April 11, 1936 and is headquartered in Saint-Laurent, Canada.

Air Canada Inc. - Ordinary Shares (Voting and Variable Voting)

Air Canada Inc.

Air Canada is trending as investors weigh strong travel demand and record bookings against concerns over rising fuel costs and geopolitical tensions impacting the airline industry. Sentiment remains mixed, with bullish focus on share buybacks and fleet expansion, while others are cautious due to volatile fuel prices and broader market uncertainty.

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, E-Vapor Products and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The E-Vapor Products segment contracts with third-party importers to supply all of its products and sells its e-vapor products to customers in the United States. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Altria Group Inc.

Altria Group is trending as investors rotate into high-yield, defensive dividend stocks amid broader market volatility and uncertainty. Community discussion highlights the company's long-term value as a 'dividend king' with a strong yield, while interest remains tempered by concerns over declining cigarette volumes and regulatory headwinds.

iShares Ethereum Trust (The) - iShares Ethereum Trust ETF

iShares Ethereum Trust ETF

ETHA is trending as traders weigh its performance relative to direct Ethereum holdings, with many discussing its long-term potential as an institutional gateway for tokenized finance. Discussion is largely divided between those advocating for long-term accumulation due to institutional adoption and others questioning the benefit of the ETF compared to holding the asset directly or alternative crypto-related equities.

Subsquid Network is an innovative decentralized data lake and query engine designed to offer developers performant and permissionless access to data, aiming to build a neutral and open internet rooted in Web3 principles. Secured by ZK proofs, the Subsquid network boasts a modular architecture that enables exceptional scalability and developer convenience optimized for blockchain indexing, dApp development, and analytics.  Subsquid is a response to unscalable and rigid monolithic indexing frameworks that had previously gained popularity and market traction among Web3 developers. Today, these frameworks are struggling to adapt in a rapidly evolving blockchain environment. Additionally, the network serves as a highly efficient and decentralized alternative to centralized infrastructure firms, including large RPC and API providers.

The conversation surrounding SQD is primarily centered on its role as decentralized infrastructure for blockchain data indexing, with bullish sentiment driven by its integration with Rezolve AI and partnerships with major enterprise entities. While supporters highlight the token's potential utility and growth in network activity as catalysts for long-term value, skeptics express concerns over price volatility and the nature of its monetization model.

KraneShares Trust - KraneShares CSI China Internet ETF

KraneShares CSI China Internet ETF

The KraneShares CSI China Internet ETF is trending due to a wave of bullish sentiment driven by strong Chinese trade data, rising optimism surrounding a potential trade deal or summit with the U.S., and positive technical signals as investors look for a rotation into oversold Chinese tech assets. Many traders are accumulating positions in anticipation of a recovery, though some community members remain skeptical, citing long-term macroeconomic concerns and historical underperformance.

Cronos is an institutional-grade, high-performance, EVM-compatible Layer-1 blockchain built on the Cosmos SDK and integrated with the Inter-Blockchain Communication (IBC) protocol, designed as the backbone for open, compliant, and AI-accessible tokenized markets. It supports up to 60,000 transactions per second (TPS), 500ms block times, instant finality, and sub-$0.01 fees via Proof of Authority consensus.

Crypto.com Coin

Investors are expressing significant frustration over recent price volatility and concerns regarding token dilution, while simultaneously reacting to reports of a major institutional investment in the associated exchange. The conversation is characterized by a sharp divide between long-term holders debating the project's long-term viability and participants engaging in speculation about potential catalysts like ETFs and ecosystem growth.

ProShares Trust II - ProShares UltraShort Bloomberg Crude Oil -2x Shares

ProShares UltraShort Bloomberg Crude Oil

Traders are actively debating oil's direction, with many using SCO as a hedge against potential geopolitical de-escalation or future recession, while others caution against the impact of volatility decay on the leveraged ETF. Sentiment remains divided between those expecting an imminent dip in crude prices and those who believe oil will remain elevated due to ongoing supply risks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Corvus Pharmaceuticals is currently driven by anticipation surrounding its clinical-stage pipeline, particularly the development of soquelitinib, with traders actively debating the stock's potential for acquisition, upcoming data readouts, and heavy short interest. While bullish investors point to institutional buying and the drug's novel mechanism of action, others express skepticism regarding management's history of delays and the company's long-term path to profitability.

Corvus Pharmaceuticals (CRVS): This Clinical-Stage Drugmaker Just Got A Lot More Interesting

Corvus Pharmaceuticals (CRVS): This Clinical-Stage Drugmaker Just Got A Lot More Interesting...

Corvus Pharmaceuticals (CRVS) Q2 2026 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Corvus Pharmaceuticals Director Buys 21,700 Shares. Does This Mean CRVS a Buy?

Key PointsDavid Scott Moore acquired 21,700 common shares for a transaction value of approximately $250,000 on June 11, 2026...

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Receives Average Rating of "Moderate Buy" from Analysts

Shares of Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS - Get Free Report) have been given an average rating of "Moderate Buy" by the eight research firms that are presently covering the stock...

Corvus Pharmaceuticals (NASDAQ:CRVS) Stock Price Down 8.3% - Here's Why

Corvus Pharmaceuticals (NASDAQ:CRVS) Shares Down 8.3% - What's Next...

Corvus Pharmaceuticals (NASDAQ:CRVS) Upgraded by Wall Street Zen to "Hold" Rating

Wall Street Zen raised shares of Corvus Pharmaceuticals from a "sell" rating to a "hold" rating in a research report on Saturday...

Corvus Pharmaceuticals (NASDAQ:CRVS) Trading Down 10.2% - Here's Why

Corvus Pharmaceuticals (NASDAQ:CRVS) Shares Down 10.2% - What's Next...

Corvus Pharmaceuticals (NASDAQ:CRVS) Shares Up 9.5% - What's Next?

Corvus Pharmaceuticals (NASDAQ:CRVS) Trading 9.5% Higher - Here's What Happened...

Corvus Pharmaceuticals (NASDAQ:CRVS) Upgraded at The Goldman Sachs Group

The Goldman Sachs Group raised shares of Corvus Pharmaceuticals to a "strong-buy" rating in a research note on Friday...

CRVS Stock Surges 10%, Hits 50-DMA For First Time In A Month – Here’s Why Goldman Sachs Sees A 166% Upside

Equity

Goldman Sachs initiated coverage of Corvus with a ‘Buy’ rating and $40 price target, according to The Fly.

Corvus Pharmaceuticals, Inc. engages in the development of product candidates for the treatment of cancer and immune-mediated and inflammatory diseases. Its product candidates include soquelitinib, an ITK inhibitor, ciforadenant, an adenosine A2A receptor antagonist, and mupadolimab, a B cell-activating anti-CD73 antibody. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Bearish Sentiment

President Trump has promised to issue a $5,000 "dividend" check to every adult American citizen if the Republican Party wins control of both the House and the Senate in the upcoming midterm elections, though the proposal would require congressional approval and follows his earlier $2,000 tariff-dividend plan, which stalled after the Supreme Court struck down much of his tariff authority. Do you think the $5,000 dividend check actually happens? Vote and explain your reasoning in the comments.

Trump has pledged a $5,000 &quot;dividend&quot; check to every adult American citizen if Republicans win control of both the House and Senate in the midterms. Do you think it actually happens?

Stocktwits

Trump has pledged a $5,000 "dividend" check to every adult American citizen if Republicans win control of both the House and Senate in the midterms. Do you think it actually happens?

Current Price	$12.91
Prev Close	$12.94
Open	$13.13
Dividend Yield	0.00%
50-Day Moving Average	$14.32
Beta	1.44
Avg. Volume	750,159.04
PE Ratio	-20.90

52-Week High	$26.95
52-Week Low	$5.64
Market Capitalization	$1.09B
EPS (Annual)	-$0.5372
Price to Book	4.82
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

CRVS Fundamentals